This strategic investment bolsters Wipro GE Healthcare’s local manufacturing footprint to address the growing domestic and international market and will build supply chain resiliency for the organisation.
As a part of this investment, the Wipro GE Healthcare ‘Made in India’ PET CT Discovery IQ will be exported to 15 countries.
Additionally, the ‘Made in India’ Revolution Aspire CT, Revolution ACT and MR breast coils will be manufactured in India for the world.
India is among the top 20 global markets for medical devices in the world.
“India is a high potential, high priority market for GE HealthCare globally,” said Peter J. Arduini, president and CEO, GE HealthCare.”We will continue to invest in expanding India’s domestic capabilities and its global footprint in MedTech manufacturing and R&D. Today’s announcement is aligned with our strategic vision to deliver precision innovation globally and accelerate India’s position as ‘MedTech innovation and manufacturing hub for India and for world,” said Arduini added.“India is riding the resurgent growth in the healthcare industry and rapidly expanding MedTech sector,” said Azim Premji, chairman, Wipro GE Healthcare.
“With ‘Make in India’, we are witnessing an exponential expansion of manufacturing footprint in the country, strengthening India’s capability as the MedTech hub of the world,” Premji added
Wipro GE Healthcare is among the first MedTech companies to ‘Make in India – for India and the world’ over past three decades, investing upwards of over $4 billion in R&D and manufacturing output in India since inception.
Wipro GE Healthcare is a joint venture (JV) between GE Precision Healthcare LLC, USA, and Wipro Enterprises Limited, India.
Established in 1990, it is one of the most successful and longest-running JVs.
Over the decades, GE Healthcare has fostered a strong local supplier ecosystem of medtech component manufacturing – covering capabilities like plastics, EMS, machining, castings, 3D printing – contributing 1000000 (1 million) supplier labor hours. The investment will include creation of additional 4 lakh labor hours.
Wipro GE Healthcare has been committed to this localisation journey for over three decades and this strategic investment is testament to our vision for this sector.” Peter J. Arduini Chaitanya Sarawate, Managing Director, Wipro GE Healthcare and President & CEO, GE HealthCare South Asia said, “Innovating in India and Making in India – for India and for the World, has always been a priority for us, evident in our trajectory and investments over past three decades. We have fostered a strong innovation track record, a local supplier ecosystem and built a portfolio of world class products in India, for India and the world.
